In a three-way randomization, 682 patients with current rheumatoid arthritis received treatment with etanercept, 25 mg subcutaneously twice weekly, oral methotrexate, up to 20 mg weekly ...

They were randomized to receive: Etanercept alone at a full dosage of 25 mg twice weekly (n=80). Etanercept 25 mg twice weekly plus anakinra 100 mg/day (n=81). Half-dose etanercept 25 mg once ...

Etanercept can bind to and neutralize extracellular tumor necrosis factor, and has proven clinical efficacy in reducing the disease symptoms of patients with rheumatoid arthritis (RA) who cannot ...

Oct. 28 -- MONDAY, Oct. 27 (HealthDay News) -- The drugs etanercept and methotrexate are safe and effective for long-term, continuous treatment of juvenile rheumatoid arthritis, new research finds.